Mazor Robotics (NASDAQ:MZOR) reported 6/30/2018 earnings this Morning, coming in at ($0.03) per share, missing Wall Street’s estimates of ($0.01) per Share. Revenue for the quarter came in at $13.20 million missing the streets estimates of $17.02 million
About Company Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company's surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.Recent Analyst Rating for Mazor Robotics (NASDAQ:MZOR)
Recent Trading for Mazor Robotics (NASDAQ:MZOR) Shares of Mazor Robotics closed the previous trading session at with 2563900 shares trading hands.